Company Monitoring Page for MannKind

latest headlines for company on cafepharma

2 Healthcare Upgrades Investors Should Consider
Seeking Alpha
Sat, 08/11/12 - 12:16 pm
Tags:
MannKind, Sanofi
3 Reasons This Speculative Bio-Pharma Is A Winner
Seeking Alpha
Sat, 08/11/12 - 11:30 am
Tags:
MannKind, Afrezza, diabetes, type 1 diabetes, type 2 diabetes
MannKind Reports Narrower 2Q Loss
Yahoo/Zacks
Thu, 08/9/12 - 11:31 am
Tags:
MannKind, earnings
MannKind 2Q loss narrows on year-ago payment
Yahoo/AP
Tue, 08/7/12 - 12:01 pm
Tags:
MannKind, earnings
Is This the End of MannKind?
Motley Fool
Sun, 07/29/12 - 12:12 pm
Tags:
MannKind
Obesity, Heart Disease And Diabetes - A Biotech Triumvirate To Profit From Healthcare Mega-Trends In The Medium Term
Seeking Alpha
Wed, 07/25/12 - 09:38 am
Tags:
obesity, heart disease, diabetes, Amarin, MannKind, Arena Pharmaceuticals
Top 20 biotech licensing deals in H1 2012
Fierce Biotech
Wed, 07/11/12 - 12:12 pm
Tags:
Xenon, Virobay, Tolero Pharmaceuticals, Threshold Pharmaceuticals, Novartis, Merck KGaA, Merck, MannKind, licensing, Janssen, Isis Pharmaceuticals, Ironwood, Inhibrx Thrombogenics, GSK, Genmab, Genentech, Galapagos, Forma Therapeutics, Endocyte, Endo, Enanta, Celgene, Bristol-Myers Squibb, Boehringer Ingelheim, Bionomics, Biogen Idec, BioDelivery Sciences, AstraZeneca, Angiochem, AC Immune, Abbott Laboratories, LEO Pharma
Are These Insiders Telling You to Buy?
Motley Fool
Sat, 07/7/12 - 11:56 am
Tags:
MannKind, Synta Pharmaceuticals
MannKind Fights On With Its Diabetes Game-Changer Afrezza
Seeking Alpha
Fri, 07/6/12 - 10:59 am
Tags:
diabetes, Afrezza, inhaled insulin, MannKind
Buy, Sell, or Hold: MannKind
Motley Fool
Sat, 06/30/12 - 03:44 pm
Tags:
MannKind
Pre-Clinical Data Demonstrates Promising Potential of MannKind’s IRE1α Inhibitor to Treat Multiple Myeloma
Yahoo
Thu, 05/31/12 - 06:26 pm
Tags:
MannKind, IRE1α inhibitor, MKC-3946, Multiple Myeloma
MannKind Narrows Loss
Yahoo/Zacks
Thu, 05/10/12 - 12:15 pm
Tags:
earnings, MannKind
MannKind Rents Out a Drug Program
Motley Fool
Tue, 05/1/12 - 12:37 pm
Tags:
MannKind, Tolero, Btk inhibitors
MannKind says it could get $130M and royalties after licensing drug candidates to Tolero
Yahoo/AP
Mon, 04/30/12 - 11:20 am
Tags:
MannKind, Tolero
MannKind: Will The Good News Ever Come?
Seeking Alpha
Wed, 04/25/12 - 10:25 am
Tags:
MannKind, Afrezza, inhaled insulin, diabetes
MannKind Narrows Loss
Yahoo/Zacks
Thu, 02/23/12 - 11:59 am
Tags:
earnings, MannKind
Easing The Pain: Why Investment In Bio-Pharma Is A Worthy Cause
Seeking Alpha
Wed, 02/1/12 - 12:19 pm
Tags:
Bristol-Myers Squibb, Ariad Pharmaceuticals, Inhibitex, Vertex Pharmaceuticals, Spectrum Pharmaceuticals, MannKind
Another Small Step Back For Mannkind
Seeking Alpha
Wed, 02/1/12 - 09:03 am
Tags:
MannKind, Jentadueto, diabetes, Afrezza
4 Biotech Stocks To Consider Buying, 2 To Sell In 2012
Seeking Alpha
Sat, 01/28/12 - 12:18 pm
Tags:
Roche Holding AG, Aeterna Zentaris, Gilead Sciences, Spectrum Pharmaceuticals, Arena Pharmaceuticals, MannKind
Biopharma Stocks To Watch This Week
Seeking Alpha
Thu, 01/19/12 - 11:12 am
Tags:
BioDelivery Sciences, Biovest International, Celldex, MannKind, NovaBay Pharmaceuticals, Keryx, ImmunoCellular, Cel-Sci, Dendreon, Generex, Human Genome Sciences

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.